The FDA is seeking comments for a proposed framework on regulating software that is used with prescription drug products. Covered apps would include apps for medication adherence, symptom tracking and patient-specific dosing, among others.
FDA issues info request for regulating software apps
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.